ID: ALA4209013

Max Phase: Preclinical

Molecular Formula: C17H19NO3

Molecular Weight: 285.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN1CCc2cc(O)c(O)cc2C1Cc1ccc(O)cc1

Standard InChI:  InChI=1S/C17H19NO3/c1-18-7-6-12-9-16(20)17(21)10-14(12)15(18)8-11-2-4-13(19)5-3-11/h2-5,9-10,15,19-21H,6-8H2,1H3

Standard InChI Key:  IIOUIJTYVIHHEI-UHFFFAOYSA-N

Associated Targets(Human)

Zone of skin 8 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Beta-2 adrenergic receptor 158 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 285.34Molecular Weight (Monoisotopic): 285.1365AlogP: 2.58#Rotatable Bonds: 2
Polar Surface Area: 63.93Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.38CX Basic pKa: 8.10CX LogP: 2.88CX LogD: 2.30
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.74Np Likeness Score: 1.19

References

1. Kato E, Kimura S, Kawabata J..  (2017)  Ability of higenamine and related compounds to enhance glucose uptake in L6 cells.,  25  (24): [PMID:29066136] [10.1016/j.bmc.2017.10.011]
2. Freitas L, Valli M, Dametto AC, Pennacchi PC, Andricopulo AD, Maria-Engler SS, Bolzani VS..  (2020)  Advanced Glycation End Product Inhibition by Alkaloids from Ocotea paranapiacabensis for the Prevention of Skin Aging.,  83  (3): [PMID:32134650] [10.1021/acs.jnatprod.9b01083]

Source